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The pathogenesis of heart failure associated with dilated cardiomyopathy (DCM) may result in part from 
adenosine triphosphate (ATP) dysregulation in the myocardium. Under these conditions, diabetes-
associated protein in insulin-sensitive tissue (DAPIT), which is encoded by the upregulated during 
skeletal muscle growth 5 (USMG5) gene, plays a crucial role in energy production by mitochondrial ATP 
synthase. To determine whether USMG5 is related to the development of heart failure, we performed 
clinical and experimental studies. Microarray analysis showed that the expression levels of USMG5 were 
positively correlated with those of natriuretic peptide precursor A in the human failed myocardium. 
When endogenous z-usmg5 in zebrafish was disrupted using morpholino (MO) oligonucleotides, the 
pericardial sac and atrial areas were larger and ventricular fractional shortening was reduced compared 
to in the control MO group. The expression levels of natriuretic peptides were upregulated in the 
z-usmg5 MO group compared to in controls. Further, microarray analysis revealed that genes in the 
calcium signalling pathway were downregulated in the z-usmg5 MO group. These results demonstrate 
that DAPIT plays a crucial role in the development of heart failure associated with DCM and thus may be 
a therapeutic target for heart failure.
Heart failure is a leading cause of mortality, even in developed countries. The prevalence of heart failure among 
the elderly population (>70 years old) is approximately 10% and is estimated to be increasing1,2. Despite improve-
ments in pharmacological and mechanical therapies, the prognosis of heart failure patients remains poor, with 
a 1-year mortality of 25–30%3. Therefore, dissecting the molecular mechanisms of heart failure progression is 
necessary to develop novel therapeutics.
Dilated cardiomyopathy (DCM) is an idiopathic cardiomyopathy condition causing progressive left ventricu-
lar enlargement and systolic dysfunction related to advanced heart failure and cardiac transplantation. Although 
gene mutations are evident in 30–35% of DCM patients4,5, the mechanism of disease progression remains unclear. 
As the heart consumes more oxygen than all other human organs, myocardial energy metabolism is an important 
factor affecting disease progression in DCM5. Furthermore, impaired adenosine triphosphate (ATP) utilization 
in the myocardium has been associated with the severity and mortality of DCM6.
Mitochondria are organelles that produce most of the cellular ATP in cardiomyocytes. In this organelle, ATP 
synthase is an important enzyme complex that generates ATP, functioning in the last step of the mitochondrial 
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oxidative phosphorylation system7,8. Diabetes-associated protein in insulin-sensitive tissue (DAPIT) is encoded 
by the upregulated during skeletal muscle growth 5 (USMG5), which is a component of the Fo subunit of the ATP 
synthase9,10 and plays a crucial role in energy production during ATP synthase11. However, the role of DAPIT 
in the myocardium has not been investigated. In this study, we hypothesized that DAPIT, a component of ATP 
synthase, plays a crucial role in the pathogenesis of heart failure associated with DCM.
Results
Expression levels of USMG5 and natriuretic peptide precursor A in failed myocardium of NICM patients. 
We first investigated whether the expression levels of USMG5 are associated with the severity of heart failure in patients 
with non-ischemic cardiomyopathy (NICM) by microarray analysis. The relative expression levels of USMG5 were 
generally positively correlated with those of natriuretic peptide precursor A (NPPA) in failed myocardium (R2 = 0.40, 
Figure 1. Microarray data revealed that the relative expression levels of USMG5 were generally positively 
correlated with those of NPPA in the failed myocardium of NICM patients (R2 = 0.40, p = 0.08) in linear 
regression analysis. NPPA: natriuretic peptide precursor A, NICM: non-ischemic cardiomyopathy.
Figure 2. Representative images of zebrafish hearts at 72 hpf. Brightfield and fluorescent microscopy images 
of zebrafish embryos injected control MO (A,B) and z-usmg5 MO (C,D), respectively. z-usmg5 MO injected 
embryos showed swollen pericardial sacs (C) and reduced ventricular contraction (D,G,H) compared to the 
control MO embryos (B,E,F). hpf: hours post fertilization, MO: morpholino oligonucleotide, Dd: diastolic 
diameter, Ds: systolic diameter.
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p = 0.08, Fig. 1). There were no significant differences in the relative expression levels of NPPA and USMG5 between 
control subjects (n = 2) and NICM patients (n = 8) (Suppl. Figure S1)
Phenotypes recapitulating heart failure induced by z-usmg5 MO injection in zebrafish 
embryos. We then examined whether knockdown of z-usmg5 induced phenotypes of heart failure in zebraf-
ish embryos. Compared to control MO-injected embryos, the percentage of embryos with a swollen pericar-
dial sac (>2 SD from wild-type embryos) was significantly greater in z-usmg5 MO-injected embryos at both 
48 and 72 hours post-fertilization (hpf) (Suppl. Figure S2). Evaluation at 72 hpf revealed no differences in heart 
rates between control MO (161 ± 12 bpm), z-usmg5 MO (158 ± 14 bpm), and z-usmg5 MO with its wild-type 
mRNA (152 ± 12 bpm) groups (Suppl. Figure S3). However, the z-usmg5 MO group (n = 19) showed a larger 
pericardial sac area (60,520 ± 16,872 μm2 vs. 32,962 ± 6,295 μm2, p < 0.0001) and atrial area (11,190 ± 1,370 μm2 
vs. 9,052 ± 1,361 μm2, p < 0.0001) than the control MO group (n = 21) (Figs 2 and 3A,B). Further, ventricular 
fractional shortening was significantly reduced in the z-usmg5 MO group compared to in the control MO group 
(16.5 ± 4.7% vs. 22.0 ± 6.0%, p = 0.003) (Figs 2 and 3D). Importantly, there were no differences in cardiac mor-
phology and function, such as pericardial area, atrial area, ventricular diameter, and ventricular fractional short-
ening between the wild-type embryos and control MO group (Suppl. Table S1).
To confirm that the observed phenotypes were specific to z-usmg5 deficiency, we conducted rescue experi-
ments. Co-injection of wild-type z-usmg5 mRNA with its MO (n = 20) resulted in a significant reduction in the 
pericardial sac and atrial areas and improvement in ventricular fractional shortening compared to injection of 
only z-usmg5 MO (Fig. 3A−D).
Figure 3. Quantitative measurements of cardiac dimensions and functions in the zebrafish embryos injected 
with control MO (control MO group, n = 21), z-usmg5 MO (z-usmg5 MO group, n = 19) and z-usmg5 MO with 
its wild-type mRNA (z-usmg5 MO with mRNA group, n = 20). Compared to the control, the MO group showed 
that the pericardial sac area (60,520 ± 16,872 μm2 vs. 32,962 ± 6,295 μm2, p < 0.0001) (A) and the atrial area 
(11,190 ± 1,370 μm2 vs. 9,052 ± 1,361 μm2, p < 0.0001) (B) were significantly increased. Although there were no 
differences in ventricular diastolic diameter (C), fractional shortening was significantly reduced in the z-usmg5 
MO group compared to in the control MO group (16.5 ± 4.7% vs. 22.0 ± 6.0%, p = 0.003) (D). These heart 
failure phenotypes caused by z-usmg5 knockdown were rescued by co-injection of its wild-type mRNA ((A–D), 
z-usmg5 MO with mRNA group). Statistical analyses were performed using Mann-Whitney U test.
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Changes in foetal cardiac genes and ATP synthase-related genes in z-usmg5 MO-injected 
zebrafish embryos. We next performed microarray analysis to examine the differences in gene expres-
sion between z-usmg5 MO-injected, control MO-injected, and wild-type embryos. Hierarchical clustering anal-
ysis revealed that differences in gene expression profiles were more evident between wild-type embryos and 
z-usmg5 MO embryos than between wild-type embryos and control MO embryos (Fig. 4A). Compared to that in 
wild-type, 2,096 genes were upregulated (Fig. 4B) and 4,298 genes were downregulated (Fig. 4C) in z-usmg5 MO 
embryos when a fold-change of 1.5 was set as the minimum.
Gene Ontology (GO) analysis revealed that 58 GO terms were upregulated and 133 were downregulated in 
z-usmg5 MO embryos compared to in wild-type embryos. Importantly, GO terms related to ATP driving intra-
cellular ions transfer, such as ATPase activity coupled to the transmembrane movement of ions (GO: 0042625), 
substrate-specific transmembrane transporter activity (GO: 0022891), and ion transmembrane transporter activ-
ity (GO: 0015075), were significantly downregulated (Table 1).
Pathway enrichment analysis revealed that 7 pathways were downregulated and 11 pathways were upregulated 
in embryos injected with z-usmg5 MO compared to in wild-type embryos (Table 2). Among the 7 downregu-
lated pathways, major factors involved in calcium signalling, such as atp2a2 encoding sarcoplasmic/endoplas-
mic reticulum Ca2+-ATPase (SERCA), slc8a1b encoding a member of proteins constituting the sodium/calcium 
exchanger (NCX), ryr3 encoding a ryanodine receptor (RyR), and atp2b3 encoding a plasma membrane cal-
cium ATPase, were significantly downregulated (p < 0.0001) in z-usmg5 MO embryos compared to in wild-type 
embryos (http://www.wikipathways.org/index.php/Pathway:WP1365; Fig. 5). Furthermore, the transforming 
growth factor β signalling pathway was significantly upregulated (p < 0.0001) in z-usmg5 MO embryos compared 
in wild-type embryos.
Figure 4. Hierarchical clustering analysis revealed that differences in gene expression profiles were more 
evident between wild-type embryos and z-usmg5 MO embryos than between wild-type embryos and control 
MO embryos (A). A Venn diagram showing that 2,096 genes were upregulated > 1.5-fold (B) and 4,298 genes 
were downregulated by > 1.5-fold (C) in z-usmg5 MO embryos compared to wild-type embryos.
GO ACCESSION GO Term p-value
GO:0051234 establishment of localization <0.0001
GO:0005215|GO:0005478 transporter activity <0.0001
GO:0006811 ion transport <0.0001
GO:0022892 substrate-specific transporter activity <0.0001
GO:0015075 ion transmembrane transporter activity <0.0001
GO:0022891 substrate-specific transmembrane transporter activity <0.0001
GO:0042625 ATPase activity, coupled to transmembrane movement of ions 0.0002
Table 1. Gene ontology analysis revealed that intracellular ATP depletion occurred in z-usmg5 MO-injected 
zebrafish embryos compared to wild-type embryos.
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Quantitative real-time PCR confirmed that z-usmg5 knockdown did not affect other components of ATP syn-
thase such as atp5a, atp5b, and atp5h (Fig. 6A). Additionally, we confirmed that the expression levels of major fac-
tors involved in calcium signalling including atp2a2, slc8a1b, ryr3, and atp2b3 were significantly downregulated 
(Fig. 6B). The expression levels of cardiac-specific sarcomere genes including vmhc (cardiac myosin heavy chain), 
myl2 (cardiac myosin light chain), and mybpc3 (cardiac myosin binding protein c) were significantly downregu-
lated in z-usmg5 MO embryos compared to the control MO embryos (Fig. 6C). Furthermore, the expression levels 
of natriuretic peptides, such as nppa (NM_198800) and nppb (NM_001327776), were significantly upregulated in 
z-usmg5 MO embryos compared to in control MO embryos (Fig. 6D).
Discussion
In this study, we demonstrated that z-usmg5 MO-injected zebrafish embryos showed (1) reduced ventricular 
contraction and pericardial sac enlargement, (2) downregulated expression levels of major factors in the calcium 
signalling pathway, and (3) gene expression fluctuations of natriuretic peptides and cardiac sarcomere-associated 
peptides. These findings indicate that z-usmg5 knockdown can cause heart failure phenotypes associated with 
DCM in zebrafish embryos.
DAPIT, encoded by USMG5, consists of 58 amino acids12 and is known to be a Fo subunit component of mito-
chondrial ATP synthase13,14. Although whether DAPIT contributes to ATP production and maintaining ATP 
concentrations in cardiomyocytes is unclear, several studies have revealed the functions of this protein. Ohsakaya 
et al. showed that mitochondrial ATP production was significantly reduced in DAPIT-depleted HeLa cells11, 
indicating that DAPIT plays a critical role in ATP production by mitochondrial ATP synthase.
ATP synthase is the major generator of ATP in the mitochondrial respiratory chain and maintains ATP con-
centrations in cardiomyocytes7. As the heart requires ATP synthesis than any other organ, cardiac dysfunction 
in z-usmg5 knockdown zebrafish embryos may result from mitochondrial ATP synthase dysfunction and sub-
sequent intracellular ATP depletion (Suppl. Figure S4)8. Indeed, our data demonstrate that GO terms related 
to ATP driving intracellular ion transfer, such as ATPase activity, were significantly downregulated in z-usmg5 
knockdown zebrafish embryos (Table 1), supporting this hypothesis. Additionally, we demonstrated that factors 
in the calcium signalling pathway, a major pathway activated in the failing heart, were significantly downregulated 
in z-usmg5 knockdown embryos (Fig. 5). ATP synthase dysfunction resulted in excessive reactive oxygen species 
(ROS) accumulation in the cytosol, which can cause calcium overload in cardiomyocytes (Fig. 5)15,16. Previous 
studies demonstrated that intracellular accumulation of ROS leads to the deterioration of the calcium regulator 
pumps in the sarcoplasmic reticulum (SR) membrane, such as RyR and SERCA, and in the cell membrane, such 
as NCX17–20. Subsequently, calcium overload may lead to cardiomyocyte apoptosis21 and myocardial fibrosis22, 
resulting in contractile dysfunction of cardiomyocytes (Suppl. Figure S4)23,24. Further, upregulation of the TGF-β 
signalling pathway (Table 2) and foetal cardiac genes (Fig. 6D) in z-usmg5 knockdown embryos may contribute 
to the development of pathological cardiac remodelling25,26. As the activity of the mitochondrial respiratory chain 
including the ATP synthase is reduced in the failing myocardium8,27, the intervention of ATP synthase-interacting 
proteins modulating ATP synthase function may be a novel therapeutic target for heart failure in DCM patients. 






Significantly activated pathways in downregulated genes
    Dr_Calcium_Regulation_in_the_Cardiac_Cell_WP1365_71502 <0.0001 43 110
    Dr_GPCRs_Class_C_Metabotropic_glutamate_pheromone_WP1373_68623 <0.0001 6 10
    Dr_Monoamine_GPCRs_WP1389_81184 0.0005 9 29
    Dr_G_Protein_Signaling_Pathways_WP1371_71520 0.0007 16 75
    Dr_Hypothetical_Network_for_Drug_Addiction_WP1333_68646 0.001 8 24
    Dr_Striated_Muscle_Contraction_WP1316_68687 0.01 7 29
    Dr_Biogenic_Amine_Synthesis_WP154_77401 0.02 4 11
Significantly activated pathways in upregulated genes
    Dr_Heme_Biosynthesis_WP1314_71976 0.001 4 8
    Dr_Nodal_Signaling_Pathway_WP341_71978 0.004 13 101
    Dr_FGF_signaling_pathway_WP152_84645 0.006 17 132
    Dr_ERK1_-_ERK2_MAPK_cascade_WP402_71500 0.008 18 153
    Dr_TGF_Beta_Signaling_Pathway_WP1370_68675 0.01 7 43
    Dr_Apoptosis_WP1351_71509 0.02 9 60
    Dr_Apoptosis_Modulation_by_HSP70_WP1392_77556 0.02 4 16
    Dr_Toll-like_receptor_signaling_pathway_WP1384_77485 0.02 10 70
    Dr_Cholesterol_Biosynthesis_WP1387_77424 0.02 4 16
    Dr_FAS_pathway_and_Stress_induction_of_HSP_regulation_WP511_68680 0.03 6 34
    Dr_Adipogenesis_WP1331_85024 0.04 12 99
Table 2. Pathway enrichment analysis using WikiPathways revealed significantly activated pathways in z-usmg5 
MO-injected zebrafish embryos compared to wild-type embryos.
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with and modulate ATP synthase function. For DAPIT, Kontro et al. showed that overexpression of DAPIT sat-
urated the respiratory chain by decreasing H+-ATP synthase activity, leading to increased mitochondrial mem-
brane potential and superoxide levels in human embryonic kidney 293 cells14. Taken together with our results, 
in which DCM phenotypes were detected in z-usmg5 knockdown zebrafish, these observations reported by 
Kontro et al. indicate that the modulation of DAPIT may be important for maintaining ATP synthase activity 
and mitochondrial respiratory function and thus improving the cardiac function in heart failure patients. Indeed, 
co-injection of wild-type z-usmg5 mRNA with z-usmg5 MO into the embryos rescued the DCM phenotypes 
induced by z-usmg5 MO alone (Fig. 3), suggesting that modulation of USMG5 mRNA levels can improve cardiac 
function. Further, expression levels of USMG5 were generally positively correlated with the severity of heart fail-
ure in NICM patients (Fig. 1), indicating that DAPIT expression is compensatory to preserve ATP production 
during the process of heart failure progression. Together, these findings suggest that DAPIT plays a crucial role in 
preserving ATP production in the failing heart and thus is a novel target molecule for DCM treatment.
There are several limitations to our study. First, our microarray data was not validated at the protein level by 
western blot analysis. However, we confirmed the major results of microarray analysis by quantitative real-time 
PCR. Second, DCM phenotypes in z-usmg5 knockdown zebrafish embryos should be carefully interpreted 
because generalized DAPIT knockdown in zebrafish may increase myocardial stress to meet the oxygen demand 
of peripheral tissues. However, systemic oxygen demand may not be significantly increased in z-usmg5 knock-
down zebrafish embryos compared to in control zebrafish embryos because heart rates were similar between 
the 2 groups (Suppl. Figure S3). Third, although we suggest that z-usmg5 knockdown can induce intracellular 
ATP depletion leading to the heart failure phenotype in zebrafish embryos, further investigations are needed to 
confirm our results and reveal the role of DAPIT in mitochondrial function. Finally, the statistical evaluations of 
NPPA and USMG5 expression levels between human control subjects and NICM patients were difficult because 
of the small sample size (control = 2). Additional study will be necessary to confirm these differences.
Our data demonstrate that z-usmg5 knockdown induced phenotypes recapitulating heart failure in human 
with reduced ventricular contraction in zebrafish embryos. DAPIT, a component of ATP synthase, may play a 
crucial role in the pathogenesis of heart failure associated with DCM and thus could be a therapeutic target for 
heart failure.
Figure 5. Pathway analysis using WikiPathways revealed that the factors related to the calcium signalling 
pathway (Kelder, T., Chichester, C., Hanspers, K.: Calcium Regulation in the Cardiac Cell (Danio rerio). http://
www.wikipathways.org/instance/WP1365_r71502) were significantly downregulated (p < 0.0001) in z-usmg5 
MO embryos compared to in wild-type embryos. Downregulated genes in z-usmg5 MO embryos with a fold 
change > 1.5 compared to wild-type embryos are highlighted in yellow boxes.
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Methods
Ethics. This study complied with the Declaration of Helsinki. All zebrafish experimental protocols were 
approved by the Animal Care and Use Committee of Kanazawa University. In addition, all the experimental 
protocols used in this study were approved by the Bioethical Committee of Medical Researches of Kanazawa 
University.
Microarray analysis using human failed myocardium. Eight RNA samples extracted from human 
failed myocardium and two samples of normal control subjects were used. Failed myocardium samples were 
obtained from patients with non-ischemic cardiomyopathy (NICM) who underwent cardiac reconstructive sur-
gery, such as a Batista or Dor procedure, after obtaining written informed consent31. The use of myocardial sam-
ples was approved by the Bioethical Committee of Medical Researches of the Osaka University (Suita, Japan). Gene 
expression levels were evaluated using a HG-U95 Affymetrix GeneChip. All expression data were normalized 
by global scaling and were analysed using GeneSpring software (Agilent Technologies, Santa Clara, CA, USA)31.
Animals. All zebrafish experiments were performed in accordance with the Guide for the Care and Use of 
Laboratory Animals (National Institutes of Health Publication, 8th Edition, 2011). Zebrafish were raised and 
maintained at 28 °C on a 14:10 h light-dark cycle. We used the hspGFF3A strain of zebrafish, which expresses 
green fluorescent protein in the heart32, to analyse the size and function of the cardiac ventricle.
Figure 6. Quantitative real-time PCR confirmed that the expression level of z-usmg5 was significantly 
downregulated in z-usmg5 MO-injected embryos. However, the expression levels of other components of 
ATP synthase such as atp5a, atp5b, and atp5h were not significantly changed (A). The expression levels of 
major factors in the calcium signalling pathway, such as atp2a2a, atp2b3a, ryr3, and slc8a1b, were significantly 
downregulated (B) and cardiac-specific sarcomere-associated genes, such as vmhc, mybpc3, and myl2, were 
downregulated (C) in z-usmg5 MO embryos compared to in control MO embryos. Furthermore, the expression 
levels of the natriuretic peptide a (nppa) and b (nppb) were significantly upregulated (D) in z-usmg5 MO 
embryos compared to in control MO embryos. *P < 0.05 compared to the respective control. Each bar indicates 
the mean ± SD of three independent experiments. White and black bars indicate control MO embryos and 
z-usmg5 MO embryos, respectively. The results are representative of three independent experiments. Statistical 
analyses were performed using Student’s t test.
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In vitro synthesis of zebrafish usmg5 mRNA. The cDNA of the wild-type zebrafish usmg5 orthologue, 
z-usmg5 (NM_001200033), was subcloned into a PCS2P + plasmid expression vector. Capped mRNA was synthe-
sized using mMESSAGE mMACHINE SP6 Transcription Kit (Thermo Scientific, Waltham, MA, USA) according 
to the manufacturer’s protocol.
Design of z-usmg5 morpholino oligonucleotides and injection. The morpholino (MO) oligonu-
cleotides were synthesized using Gene-Tools (Philomath, OR, USA). To knockdown z-usmg5, we designed a 
splice site blocking MO to disrupt the translation of z-usmg5. The sequence of the acceptor site MO was 
5′-GTATGCAATCTGTTAATAAAGGAGA-3′ and that of the donor site MO was 5′-TAATGTCGACTTA 
CATTCCTCCTGC-3′. We also designed control MOs with 5-base pair mismatches corresponding to each of 
the z-usmg5 MOs. The control MO sequences for the donor and acceptor MOs were 5′-GTATaCAATaTaTTAAT 
AAAaGAaA-3′ and 5′-TAATaTCGAaTTAaATTCaTCCTaC-3′, respectively. Both z-usmg5 MOs (2.5 ng for the 
acceptor and donor site MO) or equal amounts of control MOs were injected into the hspGFF3A zebrafish strain 
embryos at the 1-cell stage using a microinjector. For rescue experiments, we co-injected synthesized wild-type 
z-usmg5 mRNA (400 pg) with z-usmg5 MO into the embryos.
Quantification of cardiac morphology and function in zebrafish embryos. Zebrafish hearts at 72 h 
post fertilization (hpf) were recorded using a Leica digital camera (DFC 310 for colour images and DFC 365 FX 
for fluorescence images) on a fluorescence stereomicroscope M205A (Leica, Wetzlar, Germany). Cardiac mor-
phologies such as ventricular area, atrial size, and pericardial sac area were quantified with LAS AF software (ver-
sion 3.1.0; Leica). The end-diastolic ventricular dimension was measured at its largest point. Ventricular fractional 
shortening was evaluated with recorded movies converted to M-mode images using the original software31,33.
RNA extraction, cDNA preparation, and microarray analysis of zebrafish embryos. Total RNA was 
isolated from the whole bodies of 72 hpf zebrafish embryos homogenized in 500 μL of RNA BEE reagent (Tel-Test, 
Friendswood, CA, USA). Subsequently, cDNA was synthesized from extracted RNA using the One-Step reverse 
transcription PCR Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. The integrity and 
concentration of extracted RNA and cDNA were evaluated using the Nano Drop 2000 (Thermo Scientific). The 
aliquots were stored at −80 °C. We performed microarray analyses to evaluate the influence of z-usmg5 knockdown 
on gene expression of zebrafish embryos. RNA samples isolated from wild-type embryos, control MO, and z-usmg5 
MO-injected embryos were compared. Gene expression was evaluated using the GeneChip Zebrafish Genome array 
containing the probes for 15,509 genes provided by Affymetrix (Santa Clara, CA, USA). Microarray data were ana-
lysed using GeneSpring GX software (version 12.1; Agilent Technologies). Gene Ontology (GO) annotation of genes 
was obtained from the NCBI gene database. Pathway enrichment analysis was performed using the Gene Spring GX 
software importing WikiPathways (http://www.wikipathways.org)34.
Quantitative real-time PCR analysis. The primer sequences of z-usmg5 were designed using Primer3Plus 
(primer3plus.com) and additional primer sequences were taken from the literature35–38 (Suppl. Table S2). 
Quantitative real-time PCR was performed in a total volume of 25 μL, comprised of 12.5 μL of SYBR Green Master 
Mix (Thermo Fisher Scientific), 50 ng of cDNA, and 200 nM of each primer using an Stratagene Mx3000P qPCR sys-
tem (Agilent Technologies). Duplicate reactions were performed for each cDNA sample. Forty amplification cycles 
were performed, with each cycle consisting of 95 °C for 30 s followed by 60 °C for 1 min. Amplification and dissocia-
tion curves generated by the MxPro QPCR software (version 4.10; Agilent Technologies) were used for gene expres-
sion analysis. The relative quantification of expression of each gene was normalized to the gene expression of gapdh.
Statistics. All analyses were performed using commercially available software (JMP 9.0, SAS Institute, Cary, NC, 
USA). Data are presented as the mean ± SD. Demographic data were expressed as continuous and categorical varia-
bles. Comparisons between continuous variables were performed with the Student’s t test or Mann-Whitney U test. 
Categorical variables were compared using the chi-square test. P values < 0.05 were considered statistically significant.
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